Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study |
| |
Authors: | Staffan Larsson L Stefan Lohmander André Struglics |
| |
Affiliation: | 1. Center for Biotechnology and Biomedicine (BBZ), University of Leipzig, Deutscher Platz 5, 04103, Leipzig, Germany 2. Translational Centre for Regenerative Medicine, University of Leipzig, Philipp-Rosenthal-Str. 55, 04103, Leipzig, Germany 3. Fraunhofer Institute for Cell Therapy and Immunology IZI, Perlickstr. 1, 04103, Leipzig, Germany 4. GenHotel-EA3886, Evry-Paris VII Universities, 2 rue Gaston Crémieux, 91057, Evry-Genopole cedex, France 5. Statistics and Epidemiology, Institute for Medical Informatics, University of Leipzig, H?rtelstr. 16-18, 04107, Leipzig, Germany 6. Health Economics Research Unit, Department of Psychiatry, University of Leipzig, Liebigstr. 26, 04103, Leipzig, Germany 7. Medical Clinic and Polyclinic IV, University Hospital Leipzig, Liebigstr. 22, 04103, Leipzig, Germany 8. Institute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Johannisallee 30, 04103, Leipzig, Germany 9. Faculty of Medicine, University of Coimbra, Rua Larga, 3004-504, Coimbra, Portugal 10. Statistics and Genome laboratory, La genopole, 523 place des Terrasses, 91000, Evry, France 11. H?pital Sud Francilien, 59 Boulevard Henri Dunant, 91106, Corbeil-Essonnes cedex, France 12. H?pital Lariboisière, AP-HP, 2 rue Ambroise – Paré, 75475, Paris cedex 10, France
|
| |
Abstract: | Introduction The gene MICA encodes the protein major histocompatibility complex class I polypeptide-related sequence A. It is expressed in synovium of patients with rheumatoid arthritis (RA) and its implication in autoimmunity is discussed. We analyzed the association of genetic variants of MICA with susceptibility to RA. Methods Initially, 300 French Caucasian individuals belonging to 100 RA trio families were studied. An additional 100 independent RA trio families and a German Caucasian case-control cohort (90/182 individuals) were available for replication. As MICA is situated in proximity to known risk alleles of the HLA-DRB1 locus, our analysis accounted for linkage disequilibrium either by analyzing the subgroup consisting of parents not carrying HLA-DRB1 risk alleles with transmission disequilibrium test (TDT) or by implementing a regression model including all available data. Analysis included a microsatellite polymorphism (GCT)n and single-nucleotide polymorphisms (SNPs) rs3763288 and rs1051794. Results In contrast to the other investigated polymorphisms, the non-synonymously coding SNP MICA-250 (rs1051794, Lys196Glu) was strongly associated in the first family cohort (TDT: P = 0.014; regression model: odds ratio [OR] 0.46, 95% confidence interval [CI] 0.25 to 0.82, P = 0.007). Although the replication family sample showed only a trend, combined family data remained consistent with the hypothesis of MICA-250 association independent from shared epitope (SE) alleles (TDT: P = 0.027; regression model: OR 0.56, 95% CI 0.38 to 0.83, P = 0.003). We also replicated the protective association of MICA-250A within a German Caucasian cohort (OR 0.31, 95% CI 0.1 to 0.7, P = 0.005; regression model: OR 0.6, 95% CI 0.37 to 0.96, P = 0.032). We showed complete linkage disequilibrium of MICA-250 (D' = 1, r 2 = 1) with the functional MICA variant rs1051792 (D' = 1, r 2 = 1). As rs1051792 confers differential allelic affinity of MICA to the receptor NKG2D, this provides a possible functional explanation for the observed association. Conclusions We present evidence for linkage and association of MICA-250 (rs1051794) with RA independent of known HLA-DRB1 risk alleles, suggesting MICA as an RA susceptibility gene. However, more studies within other populations are necessary to prove the general relevance of this polymorphism for RA. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|